MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
MARAVAI LIFESCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.99+0.20 (+2.95%)
Close on Oct 19, 2026
- Market cap
- $1.03B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
55.5%
144M of 260M shares
Institutional holders
178
45 new, 23 sold out
Net institutional buying
23M
In Q2 2026
Insider trades, 12 months
5 buys · 2 sales
Net bought $1.63M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| 12 West Capital Management LP | 8,921,335 | 6.20% | 13G (passive) amendment | Dec 31, 2025 |
| BlackRock, Inc. | 8,580,553 | 5.90% | 13G (passive) amendment | Sep 30, 2025 |
| Israel A. Englander | 7,773,149 | 5.20% | 13G (passive) | Sep 22, 2026 |
| GTCR Investment XI LLC | 130,834,085 | 51.81% | 13G (passive) amendment | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MRVI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Gtcr LLC | 20,150,005 | 7.76% | $125.74M | – | 3.22% |
| BlackRock, Inc. | 9,970,780 | 3.84% | $62.22M | +625,512 | 0.00% |
| Braidwell LP | 8,702,921 | 3.35% | $54.31M | −1,537,243 | 2.01% |
| First Eagle Investment Management, LLC | 7,342,574 | 2.83% | $45.82M | +4,818,238 | 0.04% |
| 12 West Capital Management LP | 7,060,195 | 2.72% | $44.06M | −200,000 | 8.24% |
| Millennium Management LLC | 6,508,220 | 2.51% | $40.61M | +4,858,730 | 0.01% |
| Vanguard Capital Management LLC | 5,283,665 | 2.03% | $32.97M | −166,037 | 0.00% |
| Ophir Asset Management Pty Ltd | 4,826,698 | 1.86% | $30.12M | New | 2.48% |
| Renaissance Technologies LLC | 4,606,491 | 1.77% | $28.74M | +341,802 | 0.04% |
| Deutsche Bank AG\ | 4,304,927 | 1.66% | $26.86M | +3,446,672 | 0.01% |
| Geode Capital Management, LLC | 3,130,258 | 1.21% | $19.54M | +301,663 | 0.00% |
| State Street Corp | 2,901,706 | 1.12% | $18.11M | +472,989 | 0.00% |
| Nuveen, LLC | 2,857,580 | 1.10% | $17.83M | +2,627,433 | 0.00% |
| JPMorgan Chase & Co | 2,593,559 | 1.00% | $16.57M | +2,236,299 | 0.00% |
| Two Sigma Investments, LP | 2,255,820 | 0.87% | $14.08M | +675,980 | 0.01% |
| Monaco Asset Management SAM | 2,231,026 | 0.86% | $13.92M | −1,189,994 | 1.11% |
| Prudential Financial Inc | 2,152,154 | 0.83% | $13.43M | +2,133,684 | 0.01% |
| Citadel Advisors LLC | 2,122,598 | 0.82% | $13.25M | +638,279 | 0.00% |
| Point72 Asset Management, L.P. | 2,005,579 | 0.77% | $12.51M | −1,199,917 | 0.01% |
| Morgan Stanley | 1,908,276 | 0.73% | $11.91M | −1,411,049 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 178 | 144M | 55.5% | 45 / 57 | 53 / 23 | 44M | 21M |
| Q1 2026 | 158 | 121M | 46.8% | 28 / 51 | 52 / 24 | 17M | 18M |
| Q4 2025 | 159 | 130M | 50.2% | 25 / 45 | 57 / 22 | 18M | 16M |
| Q3 2025 | 160 | 131M | 50.4% | 29 / 47 | 46 / 18 | 12M | 11M |
| Q2 2025 | 150 | 130M | 50.0% | 20 / 56 | 45 / 52 | 14M | 16M |
| Q1 2025 | 184 | 133M | 51.0% | 42 / 61 | 51 / 41 | 27M | 47M |
| Q4 2024 | 185 | 153M | 59.0% | 27 / 66 | 63 / 57 | 28M | 23M |
| Q3 2024 | 217 | 148M | 57.1% | 47 / 66 | 67 / 35 | 32M | 22M |
| Q2 2024 | 206 | 148M | 56.9% | 41 / 72 | 70 / 43 | 28M | 21M |
| Q1 2024 | 210 | 141M | 54.4% | 35 / 75 | 71 / 47 | 20M | 17M |
| Q4 2023 | 223 | 138M | 53.2% | 55 / 81 | 64 / 32 | 32M | 30M |
| Q3 2023 | 205 | 136M | 52.2% | 30 / 97 | 56 / 46 | 30M | 21M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of MRVI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,706,103 | 1.43% | $23.13M | 0.00% | Jun 30, 2026 |
| First Eagle Small Cap Opportunity Fund | 3,242,395 | 1.25% | $21.30M | 0.73% | Jul 31, 2026 |
| iShares Russell 2000 ETF | 2,969,903 | 1.14% | $18.53M | 0.02% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 1,596,400 | 0.61% | $10.49M | 0.26% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,455,424 | 0.56% | $9.08M | 0.01% | Jun 30, 2026 |
| Meridian Contrarian Fund | 1,275,000 | 0.49% | $7.96M | 1.17% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,264,380 | 0.49% | $8.31M | 0.09% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund | 1,233,690 | 0.48% | $8.11M | 0.02% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 1,019,039 | 0.39% | $6.36M | 0.04% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 948,570 | 0.37% | $5.92M | 0.00% | Jun 30, 2026 |
| iShares Biotechnology ETF | 741,218 | 0.29% | $4.63M | 0.05% | Jun 30, 2026 |
| Fidelity Small Cap Growth K6 Fund | 659,510 | 0.25% | $4.33M | 0.09% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 638,156 | 0.25% | $3.06M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 588,858 | 0.23% | $2.83M | 0.01% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 560,314 | 0.22% | $2.69M | 0.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Bernd Brust | Chief Executive Officer, Director | 2,028,020 | 0.78% | Sep 9, 2026 |
| Carl Hull | See Remarks, Director | 477,072 | 0.18% | Nov 12, 2024 |
| Rajesh Asarpota | Chief Financial Officer | 423,486 | 0.16% | Sep 1, 2026 |
| Kurt Oreshack | General Counsel | 335,767 | 0.13% | Jun 10, 2026 |
| Christine Dolan | See Remarks | 425,318 | 0.16% | May 22, 2026 |
| Peter Michael Leddy | See Remarks | 727,177 | 0.28% | Jul 16, 2025 |
| Kevin Herde | Chief Financial Officer | 674,636 | 0.26% | May 28, 2025 |
| William E. Martin Iii | Chief Executive Officer | 1,814,643 | 0.70% | Mar 19, 2025 |
| Rebecca Buzzeo | See Remarks | 310,933 | 0.12% | Mar 19, 2025 |
| Andrew Burch | See Remarks | 369,183 | 0.14% | Jan 17, 2025 |
| Gregory T. Lucier | Director | 311,200 | 0.12% | Jun 10, 2026 |
| Sean Laurence Cunningham | Director | 184,348 | 0.07% | May 28, 2026 |
| R. Andrew Eckert | Director | 412,183 | 0.16% | May 28, 2026 |
| Luke Joseph Marker | Director | 184,348 | 0.07% | May 28, 2026 |
| Susannah Gray | Director | 216,200 | 0.08% | May 28, 2026 |
| Constantine S. Mihas | Director | 184,348 | 0.07% | May 28, 2026 |
| John A. DeFord | Director | 205,478 | 0.08% | May 28, 2026 |
| Murali Prahalad | Director | 154,607 | 0.06% | Jun 18, 2025 |
| Jessica Hopfield | Director | 199,907 | 0.08% | Jun 18, 2025 |
| Benjamin James Daverman | Director | 138,055 | 0.05% | Jun 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Bernd Brust Chief Executive Officer, Director | Sep 8, 2026 | Tax withholding | −29,250 | $7.32 | $214.11K | 1,561,249 |
| Rajesh Asarpota Chief Financial Officer | Aug 31, 2026 | Tax withholding | −5,465 | $7.68 | $41.97K | 423,486 |
| Bernd Brust Chief Executive Officer, Director | Aug 10, 2026 | Tax withholding | −29,250 | $6.23 | $182.23K | 1,590,499 |
| Rajesh Asarpota Chief Financial Officer | Jul 30, 2026 | Tax withholding | −5,465 | $6.59 | $36.01K | 428,951 |
| Bernd Brust Chief Executive Officer, Director | Jul 8, 2026 | Tax withholding | −29,250 | $5.92 | $173.16K | 1,619,749 |
| Rajesh Asarpota Chief Financial Officer | Jun 30, 2026 | Tax withholding | −65,584 | $6.39 | $419.08K | 434,416 |
| Kurt Oreshack General Counsel | Jun 10, 2026 | Sale(10b5-1 plan) | −25,000 | $5.10 | $127.50K | 335,767 |
| Gregory T. Lucier Director | Jun 9, 2026 | Gift | −46,293 | – | – | 155,123 |
| Gregory T. Lucier Director | Jun 9, 2026 | Gift | +46,293 | – | – | 156,077 |
| Kurt Oreshack General Counsel | Jun 9, 2026 | Sale(10b5-1 plan) | −25,000 | $5.06 | $126.50K | 360,767 |
| Bernd Brust Chief Executive Officer, Director | Jun 8, 2026 | Tax withholding | −351,001 | $5.02 | $1.76M | 1,648,999 |
| Constantine S. Mihas Director | May 26, 2026 | Award | +46,293 | – | – | 184,348 |
| R. Andrew Eckert Director | May 26, 2026 | Award | +46,293 | – | – | 412,183 |
| Susannah Gray Director | May 26, 2026 | Award | +46,293 | – | – | 216,200 |
| Gregory T. Lucier Director | May 26, 2026 | Award | +46,293 | $4.38 | $202.76K | 201,416 |
| Luke Joseph Marker Director | May 26, 2026 | Award | +46,293 | – | – | 184,348 |
| John A. DeFord Director | May 26, 2026 | Award | +46,293 | – | – | 205,478 |
| Sean Laurence Cunningham Director | May 26, 2026 | Award | +46,293 | – | – | 184,348 |
| Gregory T. Lucier Director | May 26, 2026 | Award | +46,293 | – | – | 201,416 |
| Christine Dolan See Remarks | May 15, 2026 | Award | +5,006 | $1.79 | $8.96K | 425,318 |
| Kurt Oreshack General Counsel | May 15, 2026 | Award | +776 | $2.84 | $2.20K | 385,767 |
| Christine Dolan See Remarks | Mar 16, 2026 | Tax withholding | −28,661 | $3.08 | $88.28K | 420,312 |
| Kurt Oreshack General Counsel | Mar 16, 2026 | Tax withholding | −39,976 | $3.08 | $123.13K | 384,991 |
| Christine Dolan See Remarks | Jan 15, 2026 | Tax withholding | −28,934 | $3.69 | $106.77K | 448,973 |
| Kurt Oreshack General Counsel | Jan 15, 2026 | Tax withholding | −31,902 | $3.69 | $117.72K | 424,967 |
| Gregory T. Lucier Director | Dec 8, 2025 | Buy | +48,528 | $3.67 | $178.10K | 155,123 |
| Gregory T. Lucier Director | Dec 5, 2025 | Buy | +51,472 | $3.70 | $190.45K | 106,595 |
| Christine Dolan See Remarks | Nov 14, 2025 | Award | +4,300 | $1.79 | $7.70K | 477,907 |
| Bernd Brust Chief Executive Officer, Director | Nov 13, 2025 | Buy | +216,212 | $3.25 | $702.69K | 466,771 |
| Bernd Brust Chief Executive Officer, Director | Nov 12, 2025 | Buy | +93,358 | $3.21 | $299.68K | 250,559 |
| Bernd Brust Chief Executive Officer, Director | Nov 11, 2025 | Buy | +157,201 | $3.24 | $509.33K | 157,201 |
| Peter Michael Leddy See Remarks | Jul 15, 2025 | Tax withholding | −5,154 | $2.59 | $13.35K | 727,177 |
| Gregory T. Lucier Director | Jul 10, 2025 | Gift | +89,139 | – | – | 109,784 |
| Gregory T. Lucier Director | Jul 10, 2025 | Gift | −89,139 | – | – | 55,123 |
| Rajesh Asarpota Chief Financial Officer | Jun 30, 2025 | Award | +500,000 | – | – | 500,000 |
| Sean Laurence Cunningham Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 138,055 |
| R. Andrew Eckert Director | Jun 16, 2025 | Award | +231,481 | $2.16 | $500.00K | 365,890 |
| Benjamin James Daverman Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 138,055 |
| Jessica Hopfield Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 199,907 |
| John A. DeFord Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 159,185 |
| Luke Joseph Marker Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 138,055 |
| Gregory T. Lucier Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 144,262 |
| Susannah Gray Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 169,907 |
| Constantine S. Mihas Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 138,055 |
| Murali Prahalad Director | Jun 16, 2025 | Award | +89,139 | $2.16 | $192.54K | 154,607 |
| Bernd Brust Chief Executive Officer, Director | Jun 8, 2025 | Award | +2,000,000 | – | – | 2,000,000 |
| Kevin Herde Chief Financial Officer | May 15, 2025 | Award | +876 | $1.67 | $1.46K | 674,636 |
| Christine Dolan See Remarks | May 15, 2025 | Award | +2,381 | $1.67 | $3.98K | 473,607 |
| Kevin Herde Chief Financial Officer | Mar 17, 2025 | Tax withholding | −8,648 | $2.64 | $22.83K | 279,282 |
| William E. Martin Iii Chief Executive Officer | Mar 17, 2025 | Award | +986,194 | – | – | 1,814,643 |
| Kevin Herde Chief Financial Officer | Mar 17, 2025 | Award | +394,478 | – | – | 673,760 |
| Christine Dolan See Remarks | Mar 17, 2025 | Award | +246,549 | – | – | 471,226 |
| Christine Dolan See Remarks | Mar 17, 2025 | Tax withholding | −5,336 | $2.64 | $14.09K | 224,677 |
| Peter Michael Leddy See Remarks | Mar 17, 2025 | Tax withholding | −5,886 | $2.64 | $15.54K | 337,853 |
| Kurt Oreshack General Counsel | Mar 17, 2025 | Award | +295,858 | – | – | 456,869 |
| Peter Michael Leddy See Remarks | Mar 17, 2025 | Award | +394,478 | – | – | 732,331 |
| Rebecca Buzzeo See Remarks | Mar 17, 2025 | Tax withholding | −4,314 | $2.64 | $11.39K | 310,933 |
| Kurt Oreshack General Counsel | Mar 17, 2025 | Tax withholding | −4,579 | $2.64 | $12.09K | 161,011 |
| Rebecca Buzzeo See Remarks | Mar 17, 2025 | Award | +295,858 | – | – | 606,791 |
| Kevin Herde Chief Financial Officer | Feb 18, 2025 | Tax withholding | −2,326 | $4.10 | $9.54K | 287,930 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kurt Oreshack Officer | Jun 10, 2026 | 25,000 | $127.50K | Jun 10, 2026 | Restricted Stock Vesting |
| Kurt Oreshack Officer | Jun 9, 2026 | 25,000 | $126.50K | Jun 9, 2026 | Restricted Stock Vesting |
| Murali Prahalad Former Director | Dec 23, 2025 | 3,951 | $13.14K | Dec 23, 2025 | Restricted Stock Vesting |
| Jessica Hopfield Former Director | Dec 19, 2025 | 53,951 | $187.53K | Dec 19, 2025 | IPO Shares |
| Kurt Oreshack Officer | Jan 31, 2025 | 25,000 | $125.75K | Jan 31, 2025 | Restricted Stock Vesting |
| Maravai Life Sciences Holdings 2, LLC Owner | May 28, 2024 | 1,531,028 | $16.50M | May 28, 2024 | Pre-IPO reorganization |
| Maravai Life Sciences Holdings, LLC Owner | May 28, 2024 | 8,409,946 | $90.66M | May 28, 2024 | Pre-IPO reorganization |